InvestorsHub Logo
Followers 0
Posts 97
Boards Moderated 0
Alias Born 07/13/2017

Re: Jesspro post# 7599

Friday, 11/09/2018 9:33:25 AM

Friday, November 09, 2018 9:33:25 AM

Post# of 17530
Hey Jess. Not one of the ARIAD crew.

I got interested in AUPH (and made about $30K) when they announced the P2 results back in 2017. I've been following this board since then. The more I looked into the company and Voclosporin, the more impressed I became. I've been adding steadily, with a little day trading mixed in to pull in some profits, so that I now have about 100K shares.

As to your question, I'm not sure Alex Denner would be a good fit, primarily because he's touted as a turnaround specialist that then looks to sell the company. It seems to me that Glickman has already done whatever turn around was needed. While Denner might be good for us as shareholders, I think the Glickman and board are also looking out for what is good for company and the patient community.

Not sure Denner would be best for that.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News